Merger and reorganization by the CSRC through Xinfu Pharmaceuticals sealed a word board
-
Last Update: 2020-06-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Xinfu Pharmaceuticals announced on the evening of July 3, the issuance of shares to buy 100% of the equity assets of Yifan Bio and Yifan Pharmaceuticals on the same day by the China Securities Regulatory Commission merger and reorganization committee in 2014 the 32nd working meeting of the review and approval, according to the restructuring plan disclosed that the proposed shell Xinfu Pharmaceuticalcompany's target company Yifan Bio, Billion Fan Pharmaceuticals, the two companies operating well, and slightly raised the target assets of 2014-2016 net profit commitmentsUy2Xinfu Pharmaceuticals announced on the evening of July 3, the issuance of shares to buy 100% of the equity assets of Yifan Bio and Yifan Pharmaceuticals on the same day by the China Securities Regulatory Commission Merger and Reorganization Committee in 2014 the 32nd working meeting review, according to the restructuring plan disclosed that the proposed shell Xinfu Pharmaceuticals company, Billion Fan Pharmaceuticals, the two companies operating well, and slightly raised the target assets of 2014 to 2016Uy2
Share it on feed
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
